Developing Marketing Authorisation Dossier of a Radiopharmaceutical: The EAEU Procedure
Bibliographic record
Abstract
INTRODUCTION . Radiopharmaceuticals (radiopharmaceutical medicinal products) are used in clinical practice to diagnose and treat a wide range of diseases. However, regulatory acts of the Eurasian Economic Union give no detailed requirements for a section dedicated to clinical documentation in the authorisation dossier currently developed as Common Technical Document (CTD) used to assess safety and effectiveness of this drug category. AIM . This study aimed to identify transparent principles used to draft clinical modules of authorisation dossiers for various types of radiopharmaceuticals based on analysed provisions of the current EAEU legislation, recommendations by international regulatory authorities, and the expertise. DISCUSSION . Drug authorisation in the EAEU and adjusting national authorisation dossiers with the broader EAEU requirements (including new countries of recognition) requires a full dataset on clinical studies of radiopharmaceuticals. Radiopharmaceuticals have a whole range of specific traits, both due to the nature of these products and their clinical use. Specific traits of radiopharmaceuticals shall be thoroughly studies and described in the dossier documents. This study analysed the current EAEU regulatory documents and recommendations given by: Swiss Agency for Therapeutic Products (Swissmedic) and Canada Ministry of Health (Health Canada). The authors developed possible scenarios of submitting full dossiers required for a radiopharmaceutical, according to their type / kind and clinical use. CONCLUSIONS . The methods described to develop dossiers for various types / kinds of radiopharmaceuticals will help drug developers and regulatory affairs managers fully comply with the authorisation procedures.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.045 | 0.086 |
| Meta-epidemiology (narrow) | 0.001 | 0.001 |
| Meta-epidemiology (broad) | 0.001 | 0.002 |
| Bibliometrics | 0.007 | 0.003 |
| Science and technology studies | 0.003 | 0.002 |
| Scholarly communication | 0.008 | 0.006 |
| Open science | 0.002 | 0.004 |
| Research integrity | 0.003 | 0.003 |
| Insufficient payload (model declined to judge) | 0.031 | 0.021 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".